Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

Application of Hereditary Renal Cell Carcinoma Risk Criteria to a Large Prospective Database.

Kushnir I, Kirk L, Mallick R, Kim RH, Graham GE, Breau RH, Lattouf JB, Violette PD, Pautler SE, Care M, Kapoor A, Jewett MAS, Wood L, Tanguay S, Heng DYC, Basappa NS, So A, Pouliot F, Reaume NM.

Clin Oncol (R Coll Radiol). 2019 Aug 1. pii: S0936-6555(19)30290-0. doi: 10.1016/j.clon.2019.07.010. [Epub ahead of print]

PMID:
31378448
2.

Venous thromboembolism and transfusion after major abdominopelvic surgery.

McAlpine K, Breau RH, Knee C, Carrier M, Violette PD, van Walraven C, McIsaac DI, Mallick R, Cagiannos I, Morash C, Lavallée LT.

Surgery. 2019 Jul 31. pii: S0039-6060(19)30337-X. doi: 10.1016/j.surg.2019.05.050. [Epub ahead of print]

PMID:
31377000
3.

Renal cell carcinoma in the Canadian Indigenous population.

Wong ECL, Breau RH, Mallick R, Wood L, Pouliot F, Basappa NS, Tanguay S, Soulières D, So A, Heng D, Lavallée LT, Drachenberg D, Kapoor A.

Curr Oncol. 2019 Jun;26(3):e367-e371. doi: 10.3747/co.26.4707. Epub 2019 Jun 1.

4.

Diabetes and kidney cancer survival in patients undergoing nephrectomy: A Canadian multi-center, propensity score analysis.

Nayan M, Jalali S, Kapoor A, Finelli A, So A, Rendon R, Breau RH, Lavallee LT, Tanguay S, Heng D, Kawakami J, Basappa NS, Bjarnason G, Pouliot F, Hamilton RJ.

Urol Oncol. 2019 Sep;37(9):576.e11-576.e16. doi: 10.1016/j.urolonc.2019.06.006. Epub 2019 Jul 5.

PMID:
31285115
5.

Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of cytoreductive nephrectomy for patients with metastatic renal cell carcinoma.

Mason RJ, Wood L, Kapoor A, Basappa N, Bjarnason G, Boorjian SA, Breau RH, Cagiannos I, Jewett MAS, Karakiewicz PI, Kassouf W, Kollmannsberger C, Lalani AA, Lattouf JB, Lavallée LT, Pautler S, Power N, Richard P, So A, Tanguay S, Rendon RA.

Can Urol Assoc J. 2019 Jun;13(6):166-174. doi: 10.5489/cuaj.5786. No abstract available.

6.

Morphologic subtyping as a prognostic predictor for survival in papillary renal cell carcinoma: Type 1 vs. type 2.

Wong ECL, Di Lena R, Breau RH, Pouliot F, Finelli A, Lavallée LT, So A, Tanguay S, Fairey A, Rendon R, Richard PO, Lattouf JB, Kawakami J, Mallick R, Kapoor A.

Urol Oncol. 2019 Jun 5. pii: S1078-1439(19)30195-4. doi: 10.1016/j.urolonc.2019.05.009. [Epub ahead of print]

7.

Development and Acceptability Testing of a Patient Decision Aid for Urinary Diversion with Radical Cystectomy.

McAlpine K, Lavallée LT, Stacey D, Moodley P, Cagiannos I, Morash C, Black PC, Kulkarni GS, Shayegan B, Kassouf W, Siemens R, So A, Leveridge MJ, Boorjian SA, Daneshmand S, Smith AB, Power N, Izawa J, Drachenberg DE, Fairey A, Rendon RA, Breau RH.

J Urol. 2019 May 17:101097JU0000000000000341. doi: 10.1097/JU.0000000000000341. [Epub ahead of print]

PMID:
31099720
8.

Assessment of quality of life, information, and supportive care needs in patients with muscle and non-muscle invasive bladder cancer across the illness trajectory.

Chung J, Kulkarni GS, Morash R, Matthew A, Papadakos J, Breau RH, Guttman D, Bender J, Jones JM.

Support Care Cancer. 2019 Feb 14. doi: 10.1007/s00520-019-4649-z. [Epub ahead of print]

PMID:
30767131
9.

Editorial Comment.

Abdi H, Breau RH.

J Urol. 2019 Mar;201(3):518. doi: 10.1097/01.JU.0000553709.74021.24. No abstract available.

PMID:
30759693
10.

Evidence-based approach to active surveillance of prostate cancer.

Witherspoon L, Breau RH, Lavallée LT.

World J Urol. 2019 Feb 6. doi: 10.1007/s00345-019-02662-5. [Epub ahead of print]

PMID:
30726506
11.

Can We Use Administrative Data to Accurately Identify Patients Who Receive a Prostate Biopsy?

Lavallée LT, Breau RH, Fergusson D, Walsh C, van Walraven C.

JCO Clin Cancer Inform. 2018 Dec;2:1-10. doi: 10.1200/CCI.17.00143.

12.

Editorial Comment.

Breau RH, Kumar R.

J Urol. 2019 Feb;201(2):331. doi: 10.1097/01.JU.0000552987.15285.c7. No abstract available.

PMID:
30634365
13.

Editorial Comment.

Breau RH, Kumar R.

J Urol. 2019 Feb;201(2):290-291. doi: 10.1097/01.JU.0000552989.61026.15. No abstract available.

PMID:
30634359
14.

Renal hypothermia during partial nephrectomy for patients with renal tumours: a randomised controlled clinical trial protocol.

Breau RH, Cagiannos I, Knoll G, Morash C, Cnossen S, Lavallée LT, Mallick R, Finelli A, Jewett M, Leibovich BC, Cook J, LeBel L, Kapoor A, Pouliot F, Izawa J, Rendon R, Fergusson DA.

BMJ Open. 2019 Jan 3;9(1):e025662. doi: 10.1136/bmjopen-2018-025662.

15.

Diagnostic Accuracy of MRI for Detecting Inferior Vena Cava Wall Invasion in Renal Cell Carcinoma Tumor Thrombus Using Quantitative and Subjective Analysis.

Alayed A, Krishna S, Breau RH, Currin S, Flood TA, Narayanasamy S, Schieda N.

AJR Am J Roentgenol. 2019 Mar;212(3):562-569. doi: 10.2214/AJR.18.20209. Epub 2018 Dec 27.

PMID:
30589382
16.

Standardized reporting templates with mandatory reporting fields and "pick-list" options improve use of Prostate Imaging and Data Reporting System version 2 in clinical practice: A plan-do-study-act analysis.

Moran K, Breau RH, Cagiannos I, Lavallée LT, Morash C, O'Sullivan J, Schieda N.

Can Urol Assoc J. 2019 Jun;13(6):212-214. doi: 10.5489/cuaj.5630. No abstract available.

17.

Robotic surgery improves transfusion rate and perioperative outcomes using a broad implementation process and multiple surgeon learning curves.

McAlpine K, Forster AJ, Breau RH, McIsaac D, Tufts J, Mallick R, Cagiannos I, Morash C, Lavallée LT.

Can Urol Assoc J. 2019 Jun;13(6):184-189. doi: 10.5489/cuaj.5527.

18.

The effect of surgery report cards on improving radical prostatectomy quality: the SuRep study protocol.

Breau RH, Kumar RM, Lavallee LT, Cagiannos I, Morash C, Horrigan M, Cnossen S, Mallick R, Stacey D, Fung-Kee-Fung M, Morash R, Smylie J, Witiuk K, Fergusson DA.

BMC Urol. 2018 Oct 19;18(1):89. doi: 10.1186/s12894-018-0403-y.

19.

A Patient Decision Aid for Men With Localized Prostate Cancer: A Comparative Case Study of Natural Implementation Approaches.

Stacey D, Taljaard M, Breau RH, Baba N, Blackmore T, Boland L, Carley M, Wu RC, Smylie J, Légaré F.

Cancer Nurs. 2018 Dec 19. doi: 10.1097/NCC.0000000000000651. [Epub ahead of print]

PMID:
30312191
20.

Canadian Urological Association guideline for followup of patients after treatment of non-metastatic renal cell carcinoma.

Kassouf W, Monteiro LL, Drachenberg DE, Fairey AS, Finelli A, Kapoor A, Lattouf JB, Leveridge MJ, Power NE, Pouliot F, Rendon RA, Sabbagh R, So AI, Tanguay S, Breau RH.

Can Urol Assoc J. 2018 Aug;12(8):231-238. doi: 10.5489/cuaj.5462. Epub 2018 May 31. No abstract available.

21.

Female radical cystectomy patients have a higher risk of surgical site infections.

Abdi H, Elzayat E, Cagiannos I, Lavallée LT, Cnossen S, Flaman AS, Mallick R, Morash C, Breau RH.

Urol Oncol. 2018 Sep;36(9):400.e1-400.e5. doi: 10.1016/j.urolonc.2018.05.023. Epub 2018 Jul 29.

PMID:
30064934
22.

ADC Metrics From Multiparametric MRI: Histologic Downgrading of Gleason Score 9 or 10 Prostate Cancers Diagnosed at Nontargeted Transrectal Ultrasound-Guided Biopsy.

Sadoughi N, Krishna S, McInnes MDF, Flood TA, Breau RH, Morash C, Schieda N.

AJR Am J Roentgenol. 2018 Sep;211(3):W158-W165. doi: 10.2214/AJR.17.18958. Epub 2018 Jul 11.

PMID:
29995495
23.

Radiotherapy with radical cystectomy for bladder cancer: A systematic review and meta-analysis.

Mcalpine K, Fergusson DA, Breau RH, Reynolds LF, Shorr R, Morgan SC, Eapen L, Cagiannos I, Morash C, Lavallée LT.

Can Urol Assoc J. 2018 Oct;12(10):351-360. doi: 10.5489/cuaj.5244. Epub 2018 May 28. Review.

24.

Images: Ruptured intratesticular arteriovenous malformation.

Capitano M, Schieda N, Robertson SJ, Morash C, Breau RH, Maciejewski C, Flood TA.

Can Urol Assoc J. 2018 Nov;12(11):E489-E491. doi: 10.5489/cuaj.5049. Epub 2018 Jun 8. No abstract available.

25.

Multiparametric magnetic resonance imaging - Transrectal ultrasound-guided cognitive fusion biopsy of the prostate: Clinically significant cancer detection rates stratified by the Prostate Imaging and Data Reporting System version 2 assessment category.

John S, Cooper S, Breau RH, Flood TA, Cagiannos I, Lavallee LT, Morash C, O'sullivan J, Schieda N.

Can Urol Assoc J. 2018 Jun 19. doi: 10.5489/cuaj.5254. [Epub ahead of print]

26.

Transforming the prostatic tumor microenvironment with oncolytic virotherapy.

Atherton MJ, Stephenson KB, Tzelepis F, Bakhshinyan D, Nikota JK, Son HH, Jirovec A, Lefebvre C, Dvorkin-Gheva A, Ashkar AA, Wan Y, Stojdl DF, Belanger EC, Breau RH, Bell JC, Saad F, Singh SK, Diallo JS, Lichty BD.

Oncoimmunology. 2018 Mar 27;7(7):e1445459. doi: 10.1080/2162402X.2018.1445459. eCollection 2018.

27.

Kidney Cancer Research Network of Canada consensus statement on the role of adjuvant therapy after nephrectomy for high-risk, non-metastatic renal cell carcinoma: A comprehensive analysis of the literature and meta-analysis of randomized controlled trials.

Karakiewicz PI, Zaffuto E, Kapoor A, Basappa NS, Bjarnason GA, Blais N, Breau RH, Canil C, Drachenberg D, Hotte SJ, Jeldres C, Jewett MAS, Kassouf W, Kollmannsberger C, Lavallée LT, Maloni R, Patenaude F, Pouliot F, Reaume MN, Sabbagh R, Shayegan B, So A, Soulières D, Tanguay S, Wood L, Bandini M.

Can Urol Assoc J. 2018 Jun;12(6):173-180. doi: 10.5489/cuaj.5187.

28.

Erectile Dysfunction: AUA Guideline.

Burnett AL, Nehra A, Breau RH, Culkin DJ, Faraday MM, Hakim LS, Heidelbaugh J, Khera M, McVary KT, Miner MM, Nelson CJ, Sadeghi-Nejad H, Seftel AD, Shindel AW.

J Urol. 2018 Sep;200(3):633-641. doi: 10.1016/j.juro.2018.05.004. Epub 2018 May 7.

PMID:
29746858
29.

Diagnostic accuracy of magnetic resonance imaging for tumour staging of bladder cancer: systematic review and meta-analysis.

Gandhi N, Krishna S, Booth CM, Breau RH, Flood TA, Morgan SC, Schieda N, Salameh JP, McGrath TA, McInnes MDF.

BJU Int. 2018 Nov;122(5):744-753. doi: 10.1111/bju.14366. Epub 2018 Jun 3.

PMID:
29727910
30.

Reducing overtreatment of prostate cancer by radical prostatectomy in Eastern Ontario: a population-based cohort study.

Witherspoon L, Lau JL, Breau RH, Knee C, Fung MFK, Morash R, Mallick R, Cagiannos I, Morash C, Lavallée LT.

CMAJ Open. 2018 Apr 30;6(2):E197-E201. doi: 10.9778/cmajo.20170149.

31.

Tranexamic Acid versus Placebo to Prevent Blood Transfusion during Radical Cystectomy for Bladder Cancer (TACT): Study Protocol for a Randomized Controlled Trial.

Breau RH, Lavallée LT, Cnossen S, Witiuk K, Cagiannos I, Momoli F, Bryson G, Kanji S, Morash C, Turgeon A, Zarychanski R, Mallick R, Knoll G, Fergusson DA.

Trials. 2018 May 2;19(1):261. doi: 10.1186/s13063-018-2626-3.

32.

Complications after minimally invasive sacrocolpopexy with and without concomitant incontinence surgery: A National Surgical Quality Improvement Program (NSQIP) database study.

Clancy AA, Mallick R, Breau RH, Khalil H, Hickling DR.

Neurourol Urodyn. 2018 Sep;37(7):2234-2241. doi: 10.1002/nau.23574. Epub 2018 Apr 10.

PMID:
29635701
33.

Age-stratified perioperative mortality after urological surgeries.

Wallace B, Breau RH, Cnossen S, Knee C, Mcisaac D, Mallick R, Cagiannos I, Morash C, Lavallée LT.

Can Urol Assoc J. 2018 Aug;12(8):256-259. doi: 10.5489/cuaj.5022. Epub 2018 Apr 6.

34.

Improving patient journey and quality of care: Summary from the second Bladder Cancer Canada-Canadian Urological Association-Canadian Urologic Oncology Group (BCC-CUA-CUOG) bladder cancer quality of care consensus meeting.

Kassouf W, Aprikian A, Saad F, Breau RH, Kulkarni G, Guttman DM, Bagshaw K, Izawa J, Eapen L, Fairey A, So A, North S, Rendon R, Sridhar SS, Brimo F, Chung P, Drachenberg D, Fradet Y, Jacobsen N, Morash C, Shayegan B, Gotto G, Zlotta A, Fleshner N, Siemens DR, Black PC.

Can Urol Assoc J. 2018 Jul;12(7):E281-E297. doi: 10.5489/cuaj.5246. Epub 2018 Mar 19. No abstract available.

35.

The efficacy and safety of topical tranexamic acid: A systematic review and meta-analysis.

Montroy J, Hutton B, Moodley P, Fergusson NA, Cheng W, Tinmouth A, Lavallée LT, Fergusson DA, Breau RH.

Transfus Med Rev. 2018 Feb 19. pii: S0887-7963(17)30151-7. doi: 10.1016/j.tmrv.2018.02.003. [Epub ahead of print] Review.

PMID:
29567052
36.

Urinary function following radical cystectomy and orthotopic neobladder urinary reconstruction.

Nayak AL, Cagiannos I, Lavallée LT, Morash C, Hickling D, Mallick R, Breau RH.

Can Urol Assoc J. 2018 Jun;12(6):181-186. doi: 10.5489/cuaj.4877. Epub 2018 Feb 23.

37.

Management of advanced kidney cancer: Canadian Kidney Cancer Forum (CKCF) consensus update 2017.

Reaume MN, Basappa NS, Wood L, Kapoor A, Bjarnason GA, Blais N, Breau RH, Canil C, Cheung P, Conter HJ, Hotte SJ, Jeldres C, Jewett MAS, Karakiewicz PI, Kollmannsberger C, Patenaude F, So A, Soulières D, Venner P, Violette P, Zalewski P, Chappell H, North SA; Kidney Cancer Research Network of Canada.

Can Urol Assoc J. 2017 Oct;11(10):310-320. doi: 10.5489/cuaj.4769. No abstract available.

38.

Long-term patient outcomes from the first year of a robotic surgery program using multi-surgeon implementation.

Montroy J, Elzayat E, Morash C, Blew B, Lavallée LT, Cagiannos I, Watterson J, Oake JS, Fungkeefung M, Thompson C, Weber R, Breau RH.

Can Urol Assoc J. 2018 Feb;12(2):38-43. doi: 10.5489/cuaj.4528. Epub 2017 Dec 1.

39.

Recommandations de l'Association des urologues du Canada sur le dépistage et le diagnostic précoce du cancer de la prostate.

Rendon RA, Mason RJ, Marzouk K, Finelli A, Saad F, So A, Violette P, Breau RH.

Can Urol Assoc J. 2017 Oct;11(10):298-309. doi: 10.5489/cuaj.4888. No abstract available.

40.

Follow-up imaging after nephrectomy for cancer in Canada: urologists' compliance with guidelines. An observational study.

Dragomir A, Aprikian A, Kapoor A, Finelli A, Pouliot F, Rendon R, Black PC, Moore R, Breau RH, Kawakami J, Drachenberg D, Lattouf JB, Tanguay S.

CMAJ Open. 2017 Dec 11;5(4):E834-E841. doi: 10.9778/cmajo.20170005.

41.

Evaluation of tumor morphologies and association with biochemical recurrence after radical prostatectomy in grade group 5 prostate cancer.

Flood TA, Schieda N, Sim J, Breau RH, Morash C, Belanger EC, Robertson SJ.

Virchows Arch. 2018 Feb;472(2):205-212. doi: 10.1007/s00428-017-2241-9. Epub 2017 Oct 3.

PMID:
28975495
42.

Follow-up Care for Survivors of Prostate Cancer - Clinical Management: a Program in Evidence-Based Care Systematic Review and Clinical Practice Guideline.

Loblaw A, Souter LH, Canil C, Breau RH, Haider M, Jamnicky L, Morash R, Surchin M, Matthew A.

Clin Oncol (R Coll Radiol). 2017 Nov;29(11):711-717. doi: 10.1016/j.clon.2017.08.004. Epub 2017 Sep 18. Review.

PMID:
28928084
43.

An assessment of Prostate Cancer Research International: Active Surveillance (PRIAS) criteria for active surveillance of clinically low-risk prostate cancer patients.

da Silva V, Cagiannos I, Lavallée LT, Mallick R, Witiuk K, Cnossen S, Eastham JA, Fergusson DA, Morash C, Breau RH.

Can Urol Assoc J. 2017 Aug;11(8):238-243. doi: 10.5489/cuaj.4093.

44.

Benchmarking quality for renal cancer surgery: Canadian Kidney Cancer information system (CKCis) perspective.

Lawson KA, Saarela O, Liu Z, Lavallée LT, Breau RH, Wood L, Jewett MAS, Kapoor A, Tanguay S, Moore RB, Rendon R, Pouliot F, Black PC, Kawakami J, Drachenberg D, Finelli A.

Can Urol Assoc J. 2017 Aug;11(8):232-237. doi: 10.5489/cuaj.4397.

45.

Development and Implementation of a Continuing Medical Education Program in Canada: Knowledge Translation for Renal Cell Carcinoma (KT4RCC).

Lavallée LT, Fitzpatrick R, Wood LA, Basiuk J, Knee C, Cnossen S, Mallick R, Witiuk K, Vanhuyse M, Tanguay S, Finelli A, Jewett MAS, Basappa N, Lattouf JB, Gotto GT, Al-Asaaed S, Bjarnason GA, Moore R, North S, Canil C, Pouliot F, Soulières D, Castonguay V, Kassouf W, Cagiannos I, Morash C, Breau RH.

J Cancer Educ. 2019 Feb;34(1):14-18. doi: 10.1007/s13187-017-1259-7.

PMID:
28779441
46.

Are renal tumour scoring systems better than clinical judgement at predicting partial nephrectomy complexity?

Kumar RM, Lavallée LT, Desantis D, Cnossen S, Mallick R, Cagiannos I, Morash C, Breau RH.

Can Urol Assoc J. 2017 Jun;11(6):199-203. doi: 10.5489/cuaj.4228.

47.

Positive surgical margins during partial nephrectomy for renal cell carcinoma: Results from Canadian Kidney Cancer information system (CKCis) collaborative.

Bansal RK, Tanguay S, Finelli A, Rendon R, Moore RB, Breau RH, Lacombe L, Black PC, Kawakami J, Drachenberg D, Pautler S, Saarela O, Liu Z, Jewett MAS, Kapoor A.

Can Urol Assoc J. 2017 Jun;11(6):182-187. doi: 10.5489/cuaj.4264.

48.

The Impact of Quality Variations on Patients Undergoing Surgery for Renal Cell Carcinoma: A National Cancer Database Study.

Lawson KA, Saarela O, Abouassaly R, Kim SP, Breau RH, Finelli A.

Eur Urol. 2017 Sep;72(3):379-386. doi: 10.1016/j.eururo.2017.04.033. Epub 2017 May 13.

PMID:
28511884
49.

Supplementary data: Maximal testosterone suppression in the management of recurrent and metastatic prostate cancer.

Klotz L, Breau RH, Collins LL, Gleave ME, Pickles T, Pouliot F, Saad F.

Can Urol Assoc J. 2017 Jan-Feb;11(1-2):E62-E63. doi: 10.5489/cuaj.4494. Epub 2017 Feb 20. Review. No abstract available.

50.

Maximal testosterone suppression in the management of recurrent and metastatic prostate cancer.

Klotz L, Breau RH, Collins LL, Gleave ME, Pickles T, Pouliot F, Saad F.

Can Urol Assoc J. 2017 Jan-Feb;11(1-2):16-23. doi: 10.5489/cuaj.4303. Review.

Supplemental Content

Loading ...
Support Center